New edition of a reference for professionals involved with treating and researching epilepsy, as well as psychiatrists and clinicians who manage patients with bipolar disorder, migraine, neuropathic pain and other conditions for which these drugs are used. The 98 chapters by medical experts cover 16 drugs, even when benzodiapines, barbiturates and hydantoins are each counted as one drug. New information includes increased emphasis on clinical trials, the importance of patient factors for obtaining optimal results with drug therapy, status epilepticus, prevention of epileptogenesis, and indications outside of epilepsy. Edited by Levy (U. of Washington Schools of Pharmacy and Medicine), Richard H. Mattson (Yale U. School of Medicine), Brian S. Meldrum (Institute of Psychiatry, London) and Emilio Perucca (Institute of Neurolgy, Pavia). Annotation copyrighted by Book News, Inc., Portland, OR.